Orchestra BioMed Holdings, Inc. financial data

Symbol
OBIO on Nasdaq
Location
150 Union Square Drive, New Hope, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 347 % -41.6%
Quick Ratio 1.12 % +38.2%
Debt-to-equity 66.2 %
Return On Equity -289 % -224%
Return On Assets -110 % -81.4%
Operating Margin -2.42K % +13.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54M shares +42.6%
Common Stock, Shares, Outstanding 38.6M shares +7.87%
Entity Public Float 125M USD +1.06%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 38.4M shares +7.24%
Weighted Average Number of Shares Outstanding, Diluted 38.4M shares +7.24%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.94M USD +41.6%
Cost of Revenue 216K USD +30.1%
Research and Development Expense 49.9M USD +33.8%
Costs and Expenses 74.2M USD +22.9%
Operating Income (Loss) -71.3M USD -22.3%
Net Income (Loss) Attributable to Parent -69.7M USD -25.4%
Earnings Per Share, Basic -1 USD/shares -16.7%
Earnings Per Share, Diluted -1 USD/shares -16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.7M USD -20.9%
Marketable Securities, Current 15.2M USD -63.4%
Accounts Receivable, after Allowance for Credit Loss, Current 83K USD +3.75%
Inventory, Net 185K USD +164%
Assets, Current 35.9M USD -46%
Property, Plant and Equipment, Net 1.37M USD +10.6%
Operating Lease, Right-of-Use Asset 1.81M USD +35.7%
Assets 42.8M USD -40.8%
Accounts Payable, Current 5.31M USD -15.4%
Employee-related Liabilities, Current 1.98M USD +11.5%
Accrued Liabilities, Current 6.65M USD +57.4%
Liabilities, Current 17.1M USD +17.6%
Deferred Income Tax Liabilities, Net 561K USD +10.4%
Operating Lease, Liability, Noncurrent 1.33M USD +20.5%
Other Liabilities, Noncurrent 189K USD
Liabilities 42.5M USD +50.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 16K USD
Retained Earnings (Accumulated Deficit) -348M USD -25%
Stockholders' Equity Attributable to Parent 99.8M USD +127788%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 295K USD -99.3%
Liabilities and Equity 42.8M USD -40.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.6M USD -26.7%
Net Cash Provided by (Used in) Financing Activities -296K USD
Net Cash Provided by (Used in) Investing Activities 13M USD +122%
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 38.6M shares +7.87%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.91M USD +45.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.7M USD -20.9%
Deferred Tax Assets, Valuation Allowance 93.9M USD +56.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.5 pure
Deferred Tax Assets, Gross 94.5M USD +55.8%
Operating Lease, Liability 1.97M USD +35.7%
Depreciation 324K USD +11%
Payments to Acquire Property, Plant, and Equipment 112K USD +1300%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -69.7M USD -25.5%
Lessee, Operating Lease, Liability, to be Paid 2.24M USD +28.9%
Property, Plant and Equipment, Gross 2.83M USD +19.1%
Operating Lease, Liability, Current 642K USD +83.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 829K USD +78.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 880K USD +160%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 271K USD -5.58%
Lessee, Operating Lease, Liability, to be Paid, Year Three 159K USD -66.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 159K USD -54.8%
Operating Lease, Payments 244K USD +7.02%
Additional Paid in Capital 348M USD +8.01%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 83K USD +12.2%
Deferred Tax Assets, Net of Valuation Allowance 561K USD +10.4%
Operating Leases, Future Minimum Payments Due 2.49M USD
Interest Expense 351K USD +48.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%